These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10917171)

  • 1. CD44 expression in soft tissue sarcomas.
    Kahara N; Ozaki T; Doi T; Nishida K; Kawai A; Shibahara M; Inoue H
    Virchows Arch; 2000 Jun; 436(6):574-8. PubMed ID: 10917171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of CD44 variants in osteosarcoma.
    Kuryu M; Ozaki T; Nishida K; Shibahara M; Kawai A; Inoue H
    J Cancer Res Clin Oncol; 1999 Nov; 125(11):646-52. PubMed ID: 10541973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44 loss in gastric stromal tumors as a prognostic marker.
    Montgomery E; Abraham SC; Fisher C; Deasel MR; Amr SS; Sheikh SS; House M; Lilliemoe K; Choti M; Brock M; Ephron DT; Zahuruk M; Chadburn A
    Am J Surg Pathol; 2004 Feb; 28(2):168-77. PubMed ID: 15043305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CD44 variant isoforms and association to the benign form of endocrine pancreatic tumours.
    Imam H; Eriksson B; Oberg K
    Ann Oncol; 2000 Mar; 11(3):295-300. PubMed ID: 10811495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of variant exon v7-v8 CD44 antigen in relation to lymphatic metastasis of human breast cancer.
    Kinoshita J; Haga S; Shimizu T; Imamura H; Watanabe O; Kajiwara T
    Breast Cancer Res Treat; 1999 Jan; 53(2):177-83. PubMed ID: 10326795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of exon v6-containing CD44 isoforms is related to poor prognosis of acute myelocytic leukemia.
    Yokota A; Ishii G; Sugaya Y; Nishimura M; Saito Y; Harigaya K
    Hematol Oncol; 1998 Dec; 16(4):131-41. PubMed ID: 10414233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD44 variant exons in leukemia and lymphoma.
    Akisik E; Bavbek S; Dalay N
    Pathol Oncol Res; 2002; 8(1):36-40. PubMed ID: 11994761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD44 isoform expression in synovial sarcoma correlates with epitheliogenesis but not prognosis.
    Sneath RJ; Mangham DC
    Histopathology; 2000 Aug; 37(2):166-74. PubMed ID: 10931241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 and variants in melanocytic skin neoplasms.
    Schaider H; Soyer HP; Heider KH; Hofmann-Wellenhof R; Zatloukal K; Smolle J; Kerl H
    J Cutan Pathol; 1998 Apr; 25(4):199-203. PubMed ID: 9609138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas.
    Tran TA; Kallakury BV; Sheehan CE; Ross JS
    Hum Pathol; 1997 Jul; 28(7):809-14. PubMed ID: 9224749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis.
    Ropponen KM; Eskelinen MJ; Lipponen PK; Alhava E; Kosma VM
    Scand J Gastroenterol; 1998 Mar; 33(3):301-9. PubMed ID: 9548625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of CD44 splice variants in human primary brain tumors.
    Kaaijk P; Troost D; Morsink F; Keehnen RM; Leenstra S; Bosch DA; Pals ST
    J Neurooncol; 1995 Dec; 26(3):185-90. PubMed ID: 8750184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD44v3 and v6 variant isoform expression correlates with poor prognosis in early-stage vulvar cancer.
    Tempfer C; Sliutz G; Haeusler G; Speiser P; Reinthaller A; Breitenecker G; Vavra N; Kainz C
    Br J Cancer; 1998 Oct; 78(8):1091-4. PubMed ID: 9792156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gains and losses of CD44 expression during breast carcinogenesis and tumour progression.
    Bànkfalvi A; Terpe HJ; Breukelmann D; Bier B; Rempe D; Pschadka G; Krech R; Böcker W
    Histopathology; 1998 Aug; 33(2):107-16. PubMed ID: 9762542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of CD44 splice variants in human stage III cervical cancer.
    Kainz C; Kohlberger P; Tempfer C; Sliutz G; Gitsch G; Reinthaller A; Breitenecker G
    Eur J Cancer; 1995 Sep; 31A(10):1706-9. PubMed ID: 7488429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CD44 isoforms in human renal cell carcinomas.
    Heider KH; Ratschek M; Zatloukal K; Adolf GR
    Virchows Arch; 1996 Jul; 428(4-5):267-73. PubMed ID: 8764936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CD44 variant proteins in adenocarcinoma of Barrett's esophagus and its relation to prognosis.
    Böttger TC; Youssef V; Dutkowski P; Maschek H; Brenner W; Junginger T
    Cancer; 1998 Sep; 83(6):1074-80. PubMed ID: 9740070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44 variant overexpression in gallbladder carcinoma associated with tumor dedifferentiation.
    Yanagisawa N; Mikami T; Mitomi H; Saegusa M; Koike M; Okayasu I
    Cancer; 2001 Jan; 91(2):408-16. PubMed ID: 11180088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44 splicing pattern is associated with disease progression in pulmonary adenocarcinoma.
    Lee LN; Kuo SH; Lee YC; Chang YL; Chang HC; Jan IS; Yang PC
    J Formos Med Assoc; 2005 Aug; 104(8):541-8. PubMed ID: 16193174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased survival in patients with CD44-negative typical bronchial carcinoid tumors.
    Granberg D; Wilander E; Oberg K; Skogseid B
    Int J Cancer; 1999 Oct; 84(5):484-88. PubMed ID: 10502723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.